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GENETIC DISORDERS - DEVELOPMENT
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Expression of polycystin in mouse metanephros and extra-metanephric
tissues. The presence of messenger RNA for the mouse homologue of the
polycystic kidney disease 1 gene (PKDI) was demonstrated by reverse
transcription-polymerase chain reaction (RT-PCR) methods in mouse
embryo messenger RNA. A single locus for the PKDJ gene was detected
on mouse chromosome 17 by fluorescent in Situ hybridization. Immuno-
precipitation of proteins from [35S1 methionine-labeled mouse metaneph-
nc explants with an anti-polycystin antibody (Pci) revealed high molecular
weight bands, the highest being >400 kDa. Immunoperoxidase staining of
mouse embryos with Pci revealed expression of polycystin as early as day
8 gestation. The expression was seen in epithelial cells of the ureteric bud,
in condensing blastemal cells of the developing metanephros and, subse-
quently, in cells of the nascent tubules. In addition, Pci immunoreactivity
was seen in hepatocytes and biliary epithelium, cardiac and skeletal
muscle, neural tissue, gut, and bronchial epithelium. In post-natal and
adult mouse kidney and liver persistent slight to moderate immunoreac-
tivity was observed. Immunofluorescent studies of cultured 13-day mouse
metanephroi revealed polycystin expression in ureteric bud epithelium,
early glomerular structures (that is, condensates, S-shaped and comma-
shaped bodies) and in proximal and distal tubular epithelia. These data
indicate that the mouse has a single gene homologous to human PKDJ on
chromosome 17, and polycystin is expressed in a variety of tissues during
embryonic development.
In 1994, PKDJ was identified as the gene that is mutated in type
1 autosomal dominant polycystic kidney disease (ADPKD1) [11.
Since then the sequence of the entire gene has been published by
three separate groups, and its predicted protein product has been
named "polycystin" [2—4]. Understanding of the functions of this
novel protein has begun with structural predictions based on the
derived amino acid sequence, identification of various mutations
in its non-duplicated carboxyl-terminal portion and immunohis-
tochemical studies of expression in fetal, adult and cystic human
tissues [5—91. These initial studies have yielded some potentially
important observations but have not clearly defined the cellular
pathogenesis of the renal and non-renal abnormalities that char-
acterize the ADPKD1 phenotype.
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Further progress in solving many of the questions relevant to
the discovery of this gene almost certainly depend on the devel-
opment of in vivo and in vitro models of polycystin expression that
can be studied systematically under basal conditions and following
defined manipulations. Because of the wealth of information
available in the literature pertaining to the developmental biology
and genetic manipulation of the mouse, this species is an obvious
choice in which the functions of the PKD1 protein can be studied.
With this in mind, we have isolated and sequenced cDNA
segments derived from different regions of the messenger RNA
transcript of the mouse homologue of PKDJ. These cDNA
segments have been used to demonstrate the absence, in the
mouse, of the homologous genes that have complicated studies of
human PKD1. Information from these cDNAs has been used to
validate the use of available reagents, such as antiserum to human
polycystin in mouse tissues [6]. Immunohistochemical studies
have been used to study the expression of polycystin in a variety of
developing and mature mouse tissues in vivo and in vitro. These
studies indicate the ubiquitous expression of polycystin, particu-
larly during embryogenesis, and establish a firm foundation for
the use of mouse model systems to define functional characteris-
tics of polycystin.
METHODS
Isolation and sequencing of mouse polycystin cDNA segments
Mouse embryos were harvested at day 18 of gestation, and were
immediately pulverized in a mortar and pestle in the presence of
liquid nitrogen. Poly-adenylated RNA was extracted from the
resulting powder using the Fastrack mRNA isolation kit (Invitro-
gen Corp., San Diego, CA, USA). Reverse transcription (RT) and
subsequent amplification of DNA by polymerase chain reaction
(PCR) methods was carried out using the GeneAmp RT-PCR kit
(Perkin Elmer, Branchburg, NJ, USA) with the following primers
derived from the human PKD 1 nucleotide sequence:
Sense: 5 '-CGTCTGCAAAGCGCCATCAA-3'
Antisense: 5 '-GCTCGGCATAATGTCTflTGCCA-3'
The same antisense primer was used for both RT and PCR.
Low stringency conditions were used for PCR (annealing temper-
ature 50°C, MgCl2 concentration 2 mM). The amplified cDNA was
subjected to low melting point agarose gel electrophoresis, and
the bands were excised and subcloned into the vector pCRII,
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using the TA cloning kit (Invitrogen Corp.) according to the
manufacturer's instructions. Subcloned cDNA products were se-
quenced, and analyzed for homology with the published sequence
for the human polycystin gene using the MacVector software
package (Oxford Molecular Group, PLC).
To obtain a second cDNA segment extending into the poten-
tially duplicated region, a further reverse transcription was carried
out using a mouse-specific reverse primer derived from the first
segment. This reaction was carried out with 220 ng of mouse
embryo mRNA using Superscript II reverse transcriptase (Gibco
BRL, Gaithersburg, MD, USA) for one hour at 42°C and 15
minutes at 70°C, following which, RNA was digested with RNase
H (Gibco BRL) at 55°C for 10 minutes. First strand eDNA was
purified using the "Glassmax" spin column system (Gibco BRL)
and eluted with 50 jl of sterile water at 70°C. Amplification by
PCR was carried out using 2.5 d of first strand eDNA and a
primer set consisting of a "nested" mouse-specific reverse primer
and a forward primer derived from the human sequence. The
approximate predicted PCR product size was 5100 bp. The DNA
polymerase mixture "Elongase" (Gibco BRL) used was used in
this reaction with a final MgC12 concentration of 1.8 mM. The
following conditions were employed in a DNA Thermal Cycler:
94°C for 30 seconds for one cycle; 94°C for 30 seconds, 50°C for
one minute, 68°C for eight minutes for 35 cycles; and 72°C for 10
minutes for one cycle.
The primers used for this second PCR were as follows:
Mouse-specific "antisense" RT primer:
5 '-AGGAAGAGTAGTGAAGCTGCCAGG-3'
Human-specific "sense" PCR primer:
5 '-CCATCArFGAGGGTGGCTCATAC-3'
Mouse-specific "antisense" PCR primer:
5 '-GAGTCGCCGTAACGCAAATG-3'
The resulting PCR product was subcloned using the TA cloning
kit and sequenced.
Screening of mouse genomic library and characterization of
genomic clones
Clones containing DNA from the mouse PKD 1 gene were
identified by screening a P1 phage mouse genomic library. Inserts
from this library are expected to be 75 to 100kb in size. Screening
was carried out as described in the protocols provided by Genome
Systems Inc. (St Louis, MO, USA) [10—13]. Primary, secondary
and tertiary screenings were carried out using a 180 bp probe
generated by PCR from the first mouse polycystin eDNA. The
primers used to generate this probe were:
Sense: 5 '-ACGTGCCTACTGGTGATACTGAC-3'
Antisense: 5 '-AGGAAGAGTAGTGAAGCTGCCAGG-3'
Based on the published nucleo tide sequence of the human PKD
I gene this eDNA probe spanned a single exon in the non-
duplicated portion of the gene. The cDNA clones to which this
probe hybridized in primary, secondary and tertiary screenings
were further characterized by hybridization with a second 138 bp
probe, predicted to localize to a separate additional exon. This
eDNA probe was generated using the primers:
Sense: 5 '-CGTGCAGTGTflTGTAGAACTCACCC-3'
Antisense: 5 '-GAGTCGCCGTAACGCAAATG-3'
The clones from the tertiary screen to which this second 138 bp
eDNA probe also hybridized were considered likely candidate
clones to include portions of the mouse PKI)1 gene. The DNAs
were prepared from four such eDNA clones. Using sequence
obtained from the second mouse polycystin DNA, a primer set
was designed to amplify a 121 bp product contained within the
single exon from the potentially duplicated region of the gene.
This primer set was as follows:
Sense: 5 '-CATCATFGAGGGTGGCTCATACC-3'
Antisense: 5'-CCAATGGAAGTTGAGGGTG-3'
The amplified PCR product was used to identify genomic
clones that contained DNA from both the "duplicated" and
"non-duplicated" portions of the mouse PKD1 gene. Confirma-
tion of DNA contigs was obtained by amplification from genomic
clone DNA of a single large product using an antisense primer




The amplified product corresponded to a region between exons
15 and 29 of the human gene.
Fluorescent in situ hybridization (FISH)
Chromosomal localization by FISH was carried out by Genome
Systems, Inc., using one of the genomic eDNA clones (F256)
described above. The DNA from clone F256 was labeled with
digoxigen dUTP by nick translation. Labeled probe was mixed
with denatured mouse unlabeled DNA and hybridized with
chromosomes in metaphase derived from mouse embryonic fibro-
blasts in a solution containing 50% formamide, 10% dextran
sulfate and 2 X SSC. Specific hybridization signals were detected
by incubating the hybridized slides with fluoresceinated anti-
digoxigen antibodies followed by counterstaining with DAPI.
Confirmation of chromosomal identity was confirmed by co-
hybridization with F256 probe and a probe known to be specific
for the telomeric region of mouse chromosome 17. In total,
chromosomes from 80 metaphase cells were analyzed and 74
exhibited specific labeling.
Generation of polyclonal antisera
The generation of a panel of rabbit polyclonal antisera against
four synthetic peptide antigens, derived from the predicted amino
acid sequence of the non-duplicated portion of human polycystin,
and their use in immunohistochemical studies of human tissues
has been detailed previously [6]. One of these antisera (Pci) was
selected for potential immunodetection of the mouse polycystin
homologue.
Collection of mouse embryo, post-natal and adult tissues
Timed pregnant mice were sacrificed daily between gestational
days 8 and 18. Embryos were harvested and fixed in 4% formal-
dehyde in phosphate buffered saline (PBS), pH 7.5 at 4°C. Mice at
one, three and six months age were sacrificed, and kidney and
liver tissues were immediately removed and fixed in 4% formal-
dehyde in PBS, pH 7.5 at 4°C. Formaldehyde fixed tissue speci-
mens were embedded in paraffin and 4 jxm-thick sections were
prepared for immunohistochemical studies.
Mouse metanephric culture
Metanephroi were dissected from day 13 Swiss-Webster mouse
embryos and cultured in a serum-free medium as previously
described [14, 15]. Freshly dissected explants were placed on 0.8
jim filters and floated on the medium in 35 mm petri dishes.
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Metanephroi were maintained for four days in a humidified
incubator at 37°C in a mixture of 95% air and 5% CO2. The
medium used was a mixture of of equal volumes of Dulbecco's
modified Eagle's medium and Ham's Nutrient mixture F12 (Sig-
ma Chemical Co., St. Louis, MO, USA), supplemented with
transferrin (50 jxg/ml), penicillin (100 UIml) and streptomycin
(100 xg/ml), pH 7.4.
Immunoprecipitation
Metanephric explants, harvested at day 13 of the gestation,
were radiolabeled in an organ culture system with (35S)methi-
onine (250 jxCi/ml; Amersham Corp., Arlington Heights, IL,
USA). After 24 hours, the explants (—30) were removed and
washed with fresh culture medium. They were then extracted with
3 ml of 6 M guanidine-HC1 solution, containing 50 m'vi Tris-HC1,
pH 7.5, 10 m'vi EDTA, 10 mrvi benzamidine-HC1, 10 mM c-amino-
n-caproic acid, 5 mrvi N-ethylmaleimide, 2 mivi phenyl-methane-
sulfonyl fluoride (PMSF) and 2 m'i diisopropylfluorophosphate
(DIFF) at 4°C for 24 hours. The homogeneates were centrifuged
at 13,000 X g for five minutes at 4°C, and the supernatant was
saved. To the supernatant 10 volumes of cold ethanol was added,
and precipitation carried out at —20°C for 12 hours. The precip-
itate was recovered by centrifuging at 15,000 X g for one hour at
4°C, and was dissolved in 3 ml immunoprecipitation buffer,
containing 50 m'vi Tris-HC1, pH 7.5, 50 msi NaC1, 0.02% NaN3,
1% Triton-X-100 and 0.25 mrvi dithiothreitol (DTT) and protease
inhibitors. Immuno-precipitation was performed by adding 10 xl
of IgG fraction of Pci antibody to 0.5 ml of the supernatant,
containing —1.0 x 106 dpms. The mixture was gently swirled in an
orbital shaker for 18 hours, following which 100 pJ of protein A
Sepharose 4B (Pharmacia LKB Biotechnology, Piscataway, NJ,
USA) was added to the antigen:antibody complex and mixed for
two hours. Subsequently, the pellets were prepared by microfug-
ing the complexes for one minute, and washing four times with
immunoprecipitation buffer. The immunoprecipitated complexes
were then dissolved in a sample buffer, and subjected to 5%
SDS-PAGE under reducing conditions. The gels were fixed in
10% acetic acid, treated with 1 M salicylic acid, dried, and
autoradiograms prepared. In the control experiments, the immu-
noprecipitation was performed with rabbit preimmune serum and
Pci antibody absorbed with the synthetic mouse or human
peptide.
Immunoperoxidase histochemistry of mouse tissues
Immunoperoxidase studies were carried out as previously de-
scribed [6]. Rabbit polyclonal antiserum Pci was used in both
crude and affinity purified forms. Pre-immune serum and immune
serum pre-absorbed with the relevant human or mouse peptide
antigens were used as controls. Antisera were used at 1:1000
dilution. Briefly, tissue sections were deparaffinized in xylene,
rehydrated in graded series of ethanol, and rinsed in distilled
water. Endogenous peroxidase activity was blocked using 50%
methanol/1.5% H202. Sections were microwaved in 10 m citrate
buffer, pH 6.0, for four minutes, blocked with 5% normal goat
serum in PBS, 0.05% Tween 20 for 10 minutes, and incubated
with primary antibody for 60 minutes and then with 1:400
biotinylated goat anti-rabbit IgG followed by 1:500 peroxidase-
labeled streptavidin for 30 minutes at room temperature. Sections
were developed in 0.1 M sodium acetate, pH 5.2, with aminoethyl
carbazole and H202, and were counterstained with hematoxylin.
Immunofluorescence histochemistry of cultured metanephric
organs
Immunofluroescence microscopy was performed on tissues
from 13-day-old embryonic metanephroi as previously described
[14, 15]. Embryonic kidneys were snap frozen in chilled isopen-
tene and embedded in OCT compound. Four-jxm-thick cryostat
sections were prepared, air dried and hydrated with PBS, pH 7.4.
They were then successively incubated with PcI FITC-goat anti-
rabbit IgG antibody for 30 minutes each, and washed with PBS.
Finally, the sections were coverslip mounted after placing a drop
of buffered glycerol, and examined with an UV microscope
equipped with epi-illumination.
RESULTS
Isolation and sequencing of mouse polycystin cDNAs
The initial RT-PCR, using human sequence primers, yielded
two PCR products of the predicted size. These were subcloned,
sequenced and compared with the sequence for the human PKD
1 gene. One of these had 75% to 80% nucleotide homology to
FKDI, and clearly represented the putative DNA segment. This
segment corresponded to the portion of the human PKDJ gene
between 11306 and 12273 nucleotide residues that lies entirely
within the non-duplicated region [2, 4]. The second round of
RT-PCR, using a mouse-specific reverse primer, resulted in a
single amplified product of the anticipated size. This cDNA
corresponded, as expected, to a portion of the human PKDJ gene
between 6908 and 11797 residues. In the human PKD1 gene this
region contains portions of both the duplicated and non-dupli-
cated regions [2, 4].
Chromosomal localization of mouse PIWJ gene
The sequence derived from mouse polycystin cDNA segments
was used to screen a mouse library that contains large genomic
DNA inserts (detailed in the Methods section). Four clones were
shown to contain cDNA corresponding to human exon 35, which
is within the unique part of the gene. These were then screened by
PCR for the presence of exonic DNA from the "duplicated"
region. Three of these clones yielded an amplification product of
the expected size, which corresponds to part of human exon 15 [4].
The expected continuity between these two exons was confirmed
by amplification of a single band of the predicted size (approxi-
mately 11 kb) from the genomic clone DNA using a forward
primer from the "duplicated" region and a reverse primer from
the unique region. DNA from one of these clones was then used
for chromosomal localization using FISH. This demonstrated
specific labeling of a single locus on mouse chromosome 17 (Fig.
1). Measurements of 10 specifically hybridized chromosomes
demonstrated that the mouse PKD1 gene is located at a position
which is 19% of the distance from the heterochromatic-euchro-
matic boundary to the telomere, which is an area of known
synteny to the region of human chromosome 16 that includes the
PKD1 gene [16].
Anti-polycystin antiserum for use in mouse tissues
The rabbit polyclonal antiserum Pci was raised against a
synthetic peptide derived from the published human polycystin
amino acid sequence. The equivalent mouse amino acid sequence
was deduced from the first eDNA described above. The human
and mouse sequences were as follows:
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Fig. 1. Fluorescent in situ hybridization (FISH) of a genomic DNA probe to mouse chromosomes in metaphase. The probe contains a portion of the
mouse PKD1 gene encompassing both duplicated and non-duplicated regions of the human gene. A single locus is identified (arrows) on a chromosome





The high degree of homology betveen the peptides allowed us
to use the antiserum for studying the distribution of polycystin in
mouse tissues. Absorption of Pci antiserum with human or mouse
peptide was equally effective in abolishing signal in immunohis-
tochemical or immunoprecipitation experiments.
PKD protein expression in mouse metanephric explants
Immunoprecipitation of labeled proteins from cultured mouse
metanephroi, harvested at day 13 of gestation, revealed tvo major
bands, one near the stacking region of the gel with molecular
weight of —400 and another one with —245 kDa size (Fig. 2, lane
1, large arrows). The ——245 kDa band may be due to proteolytic
degradation of the native 400 kDa PKD protein. A few minor
bands with lower molecular weight of —100 kDa and ——25 kDa
were also observed (Fig. 2, lane 1, small arrows). No high
molecular weight bands were seen in the autoradiogram when the
immunoprecipitation was carried out with rabbit preimmune
serum, documenting the specificity of the antibody (Fig. 2, lane 3).
Very faint bands of the size of -—-400 kDa, —100 kDa and —25 kDa
were seen in the autoradiogram when the immunoprecipitation
was performed with the antibody previously absorbed with mouse
peptide, suggesting that the antibody is specifically directed
against the synthetic peptide (Fig. 2, lane 2).
Expression of polycystin in mouse tissues
Immunostaining for polycystin was detectable in mouse embry-
onic tissue at day 8 of gestation in ectodermal, endodermal and
mesodermal structures (not illustrated). No significant staining
was observed with pre-immune and pre-adsorbed control sera.
Affinity-purified immune serum yielded a similar staining pattern
compared to crude immune serum. The controls yielded consis-
tent results in all the tissues examined. The immunostaining
revealed intra-cytoplasmic distribution of polycystin. Figures 3
and 4 show examples of immunostaining patterns for polycystin in
specific mouse embryonic tissues, harvested at various stages of
the gestation.
Figure 3 examplifies the immunostaining of polycystin in devel-
oping mouse metanephric tissue at day 12 and day 16 of gestation,
the period when the major elements of nephrons are formed. At
day 12, polycystin expression was detected in the branches of
ureteric bud epithelium with weaker staining of the condensing
mesenchymal cells. Between gestational days 13 and 16, expres-
sion remained strong in epithelia derived from the ureteric bud.
During this period, epithelia derived from metanephric blastema
(S-shaped and comma-shaped bodies and elongating tubules)
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1 2 3 of hepatocytes and biliary epithelium (not illustrated). The inten-
sity of immunostaining in the hepatocytes was generally less
compared to other mouse embryonic tissues, and it did not
diminish at one and six months of age.
Expression of polycystin in mouse metanephric culture
139—
80—
Immunofluorescence microscopy revealed reactivity of anti-Pci
antibody with the cell membranes of ureteric bud branches (Fig.
6A) and nascent nephrons of the 13 day metanephros, that is,
condensate and S-shaped bodies (Fig. 6B). No significant staining
was observed in the mesenchymal components of the metane-
phros. After four days in culture, the immunoreactivity of the cell
membranes of the ureteric bud and differentiated epithelial
structures persisted (Fig. 6C, arrowheads). However, the intensity
of staining over the structural elements, representing the transi-
tional stage between S-shaped body and precapillary stage of the






Fig. 2. SDS.PAGE analyses of immunoprecipitated de novo synthesized
products by embryonic mouse metanephroi, harvested at day 13 and
labeled with (35S)methionine. Lane I represents the immunoprecipitation
of radiolabeled proteins with anti-Pci antibody. Two major bands of high
molecular weight, that is, —400 kDa and —240 kDa, are observed (large
arrows). In addition, faint bands of low molecular weight of —100 kDa and
—25 kDa are also observed (small arrows). No bands are detected with
(32S)-methionine-labeled proteins were immunoprecipited with rabbit
preimmune serum (lane 3). Very faint bands of high and molecular weight
arc observed when antibody previously absorbed with the synthetic mouse
peptide was used (lane 2), suggesting that the antibody is specifically
directed against the synthetic peptide. The arrow head indicates the
sample application point, and the asterisks represent the dye front.
uretcric bud. Towards the end of gestation, only parietal epithelia
of mature glomeruli exhibited immunoreactivity. Immunoreactiv-
ity of polycystin in developing renal epithelium was confined to
the cytoplasm only.
In non-renal developing tissues (Fig. 4), at gestational day 9 and
16, immunostaining was present in a variety of developing organs.
These included staining of hepatocytes and biliary epithelium,
neural crest, brain, choroid plexus and ganglia, cardiac myocytes,
intestinal epithelial cells, bronchial epithelium and skeletal mus-
cle. The polycystin had a predominant cytoplasmic distribution in
all the tissues examined.
In post-natal and adult mouse kidney at one, three and six
months of age mild to moderate immunostaining of polycystin was
seen within epithelial cells of proximal and distal tubules and of
collecting ducts as well as in glomerular parietal epithelial cells
(Fig. 5). The interstitium, vasculature and other glomerular
components did not show significant staining. Mouse liver at
comparable ages demonstrated mild to moderate immunostaining
Murine models of polycystic kidney disease that develop due to
spontaneous mutation or through random mutagenesis experi-
ments have yielded considerable information in the study of cystic
disease [17]. As their phenotypes often resemble human autoso-
mal recessive or autosomal dominant polycystic kidney disease, a
primary goal in the study of such models has been to generate new
insight into the pathophysiology of these two conditions. In recent
years, experimental work in this area has expanded to the
identification of candidate genes and modifying gene loci [18—20],
the cloning of the gene responsible for one mouse cystic disease
[21] and, in this same model, the partial "rescue" of the disease
phenotype by transgenic technology [221. In addition, the targeted
de-activation ("knockout") of certain mouse genes has been
found to result in the development of polycystic kidneys [17, 23,
24]. With the recent discovery of the genes (PKDJ and PKD2) that
are responsible for the two major subtypes of ADPKD [1, 25], we
now have the prospect of using existing technologies to develop
murine models that truly represent this common, multisystem
disease. A model of ADPKD would allow the systematic study of
the protein products of the normal and mutated genes, the
identification of modifying genetic and environmental factors and
the testing of interventional strategies aimed at understanding the
progression of its renal and non-renal manifestations.
The purpose of this study was to characterize the mouse
homologue to PKDJ and its product (mouse polycystin) and to
compare its developmental expression with existing reports of
polycystin expression in human tissues. As recently reported by
Olsson and colleagues [16], mouse PKDJ is a single-copy gene. A
large genomic probe shown to contain substantial parts of the
region, which in its human counterpart is duplicated in a cluster of
closely related genes on the same chromosome, clearly hybridizes
to a single locus on mouse chromosome 17. It suggests that studies
of mouse polycystin expression and function will not be compli-
cated by the need to distinguish this protein from the products of
closely related genes.
Partial sequencing of the mouse PKDI gene has allowed us to
employ a rabbit polyclonal antiserum, raised against a peptide
derived from human polycystin sequence, to trace mouse polycys-
tin expression through embryonic development. Western blot
analysis of cultured metanephroi with the antibody showed high
molecular weight bands (>400 kDa) and lower molecular weight
244 —
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Fig. 3. Immunoperoxidase staining with Pci of developing mouse metanephros with anti-polycystin antiserum. (A) Day 12½ (X200). Branching
ureteric bud epithelium exhibits a predominant cytoplasmic distribution (closed arrow). Condensation of mesenchymal cells forming a cap over the
advancing ureteric bud tip (open arrow) also shows immunostaining. (B) Prc-adsorbtion of immune serum with the relevant peptide antigen abolishes
this staining. (C and D) Day 14 (x200 and x400). Ureteric bud epithelium continues to immunostain for polycystin (closed arrow) while the
metanephric blastema has formed early glomerular structures which stain with equal intensity (open arrow). (E and F) Day 16 (X200 and )< 400). Deeper
glomerular precursors have developed a globular shape the center of which stains with less intensity than the Outer epithelium (open arrow). Elongating
tubules continue to exhibit immunostaining with a cytoplasmic distribution (closed arrow).
bands similar to those reported by others in human tissues [6, 8]. (kidney, liver, heart, gut) may be affected in ADPKD, butsome, most
We find that the protein is expressed in early embryonic life and notably neural tissue where strong expression was demonstrated, are
continues to be expressed in developing tissues of diverse origin not. Of specific interest, early renal development was characterized
throughout the major stages of organogenesis. Many of these tissues by expression of polycystin within epithelial cells of the ureteric
I -
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Fig. 4. Immunoperoxidase staining of non-renal developing mouse tissues with anti-polycystin antiserum Pci. (A) Dorsal root ganglia (day 13; x200).
Ganglia cell bodies (arrow) immunostain strongly with a cytoplasmic distribution. (B) Pre-adsorption of immune serum with the relevant peptide antigen
abolishes this staining pattern. (C) Choroid plexus and cerebral cortex (day 13; X200). Cells lining the choroid plexus (closed arrow) and cortical cell
bodies (open arrows) show strong immunostaining. (D) Liver (day 12; x200). Hepatocytes show irnmunostaining of cytoplasm. (E) Heart (day 14;
x 100). The developing myocardium (arrow indicates atrial wall) demonstrates moderate immunostaining. (F) Gut (day 16; ><200). Epithelial cells lining
the developing intestine stain strongly for polycystin while smooth muscle cells in the wall show moderate staining.
bud, followed by expression in condensing cells of the metaneph- hum, which is contiguous with the proximal tubular epithelium.
nc blastema. Subsequently, elongating tubules derived from both Overall, the results of polycystin immunohistochemistry in mouse
structures express polycystin while maturing glomeruli lose immu- embryos closely resemble those reported in studies of human fetal
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Fig. 5. Immunoperoxidase staining of maturing mouse kidney with anti-polycystin antiserum Pci. (A and B) One month after birth (X 200 and X400).
Moderate staining of tubular epithelial cells is seen with cytoplasmic distribution. Cells of the glomeruli do not stain (arrow). (C) Three months (X200)
and (D) six months (x200). Moderate tubular epithelial staining persists.
and mouse merits comment. We have previously observed a lack
of immunostaining within S-shaped and comma-shaped bodies in
human embryonic kidney at twenty weeks gestation, while epithe-
hal cells of elongating tubules demonstrated a definitive immu-
nostaining [6]. While these immunohistochemical findings may
represent a true difference in protein expression patterns between
the two species, we believe a more likely explanation lies in the
superior tissue fixation that is possible with whole embryo speci-
mens from mouse.
Similar to the expression of polycystin in other maturing organs,
persistent immunostaining of renal tubular epithclial cells along
the entire length of the nephron was observed at one to six months
of age after birth. Such expression has been previously observed in
human tissues up to four years of age, while adult kidney and liver
showed little or no immunostaining [6]. Other investigators have
reported tubular epithelial cell staining and PKDI mRNA expres-
sion in adult human kidney, though direct comparison with the
level of expression in fetal or immature tissue has not been made
[5, 7]. We believe that, in both human and mouse, polycystin
expression is highest during organ development and persists at a
lower level thereafter.
We also report here the detection of polycystin within tubular
epithehial cells of an in vitro organ culture model—the mouse
metanephric culture—in which developing kidney is explanted into
serum-free medium soon after the invasion of undifferentiated
metanephric mesenchyme by the ureteric bud. The metanephric
explants progress through tubular and glomerular development
while lacking vascular structures [14]. As such it may prove to be
a valuable tool to study the roles of polycystin in renal tubulogen-
esis. The comparison of immunofluorescent studies of frozen
metanephric culture tissue with the immunoperoxidase studies of
formaldehyde-fixed whole embryos also raises an important point
for discussion. While polycystin is predicted to be a surface
membrane protein based on sequence analysis, a number of
groups have reported predominantly cytoplasmic staining of cells
in a variety of tissues using immunoperoxidase methods [5—7].
More recently, immunostaining of surface membrane in fetal
tissues has been reported [8, 26—28]. These studies have tended to
utilize immunofluorescence techniques. While each antiserum will
clearly have unique properties, it is important to emphasize that
there has been general agreement on expression characteristics at
a tissue level. A number of groups have also independently
reported specific over-expression of polycystin in ADPKDI tis-
sues [5—8], a finding which draws additional support from the
evidence of increased amounts of PKD1 message in affected
kidney [29]. It is likely, therefore, that different staining patterns
1204 Gnffin et a!: Expression of polycystin in mouse metanephros
Fig. 6. Immunotluoresence micrographs of day 13 mouse metanephroi cultured in serum-free medium for 24 hours (A and B) and four days (C and
D), and stained with antiserum Pci. After 24 hours (A and B), immunoreactivity is observed on the cell membranes of ureteric bud branches (U) and
nascent nephrons, that is, the S-shaped body (S). After four days (C), the immunoreactivity is still detectable in the cell membranes of ureteric bud
branches (U) and differentiating epithelial elements (arrowheads); however, the immunoreactivity is notably less in the nascent nephrons that represent
the transitional stage between the S-shaped body and precapillary stage of the glomerulus (SIP). No immunoreactivity is observed in the undifferentiated
mesencyme.
at a cellular level may predominantly reflect the methods used for
tissue fixation and immunostaining. It may well be that part or all
of the polycystin protein is present at both the surface membrane
and in cytoplasmic structures and that the method of tissue
preparation determines the site at which a specific antibody
preferentially binds. Whether mislocation of abnormal or normal
protein occurs in ADPKDI remains to be determined.
Having confirmed that mouse and human polycystin have
similarities in protein structure, distribution and expression pat-
terns, it would seem reasonable to predict that a mouse knockout
of PKDJ will result in a similar phenotype to the human disease.
Perhaps the greatest determinant of this, however, may be the
mechanism by which heterozygous mutations result in renal
cytogenesis and other slowly progressive structural abnormalities,
such as vascular aneurysms. While the aforementioned finding of
over-expression in tissues from individuals with ADPKD1 might
seem to favor a "gain of function" or "dominant negative"
mechanism, there has been recent evidence presented for "second
hit" mutations to the normal allele occurring in cells lining cysts
from affected kidneys [301. This two-hit model would readily allow
for the recognized influence of additional genetic and environ-
mental influences on disease progression, but suggests an intrinsic
instability of a gene which has yet to be characterized [291. If it
proves to be the only route to cystogenesis then phenotypic
expression will be dependent primarily on the rate of somatic
mutation and the time at which it appears in the normal PKDI
gene. The shorter gestation and lifespan of the mouse might not
allow for the development of significant polycystic disease without
additional mutagenic interventions. It may be possible to gain
further insight into this issue by using in vitro models such as the
mouse metanephric culture in which polycystin expression could
be partially or completely blocked. Aside from the consideration
of its phenotype it is clear that a targeted, in vivo disruption of
mouse PKD1, either by homologous recombination or by targeted
mutation, will be an invaluable resource in the study of polycystin
function. It is likely that this function is complex and that its
nature or importance may vary from one tissue to another.
In conclusion, these studies define the essential characteristics
of the mouse homologue to human PKDJ and its protein product,
and suggest the relevance of polycystin to normal and abnormal
human physiology. Such studies will he greatly aided by the
finding that no closely homologous genes are present in the
murine genome as well as by the wealth of recent technical
advances in the genetic manipulation of this species. Whether a
true murine model of ADPKD1 will emerge that would allow the
development of therapies to prevent progression to end-stage
renal failure in this disease remains to be determined.
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